Global Arrhythmia Monitoring Devices Market, By Type (Electrocardiogram (ECG) Monitors, Implantable Monitors, Holter Monitors, Mobile Cardiac Telemetry), Application (Tachycardia, Bradycardia, Atrial Fibrillation, Ventricular Fibrillation, Premature Contraction, Others), End-User (Hospitals and Diagnostic Centers, Ambulatory Centers) – Industry Trends and Forecast to 2030.
Arrhythmia Monitoring Devices Market Analysis and Size
According to the American Heart Association, about half of all adults in the U.S. suffer from cardiovascular disease, affecting more than 130 million individuals by 2035. Cardiac arrhythmias, such as tachycardia and bradycardia, are more common in those with severe cardiovascular disorders, and they must be closely managed to avoid abrupt heart failure. Pre-monitoring and pre-diagnosis can help you avoid most types of cardiovascular disease. Arrhythmias, or disturbances in the heart's function, can also be prevented with early detection.
Data Bridge Market Research analyses that the arrhythmia monitoring devices market which was USD 5,213.54 million in 2022, would rocket up to USD 10,528.56 million by 2030, and is expected to undergo a CAGR of 6.70% during the forecast period. This indicates that the market value. “Electrocardiogram (ECG) Monitors” dominates the type segment of the arrhythmia monitoring devices market owing to rise in pet adoption. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Arrhythmia Monitoring Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Electrocardiogram (ECG) Monitors, Implantable Monitors), Application (Tachycardia, Bradycardia, Atrial Fibrillation), End-User (Hospitals and Diagnostic Centers, Ambulatory Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
iRhythm Technologies, Inc. (U.S.), Medi-Lynx Cardiac Monitoring, LLC. (U.S.), AliveCor, Inc. (U.S.), B-Secur (U.K.), CardioComm Solutions Inc. (Canada), General Electric (U.S.), Medtronic (Ireland), Abbott (U.S.), NIHON KOHDEN CORPORATION (Japan), Koninklijke Philips N.V. (Netherlands), Baxter (U.S.), BIOTRONIK (Germany), OSI Systems, Inc. (U.S.), FUKUDA DENSHI (Japan), BioTelemetry (U.S.), Spacelabs Healthcare (U.S.), among others
|
|
Market Opportunities
|
|
Market Definition
Arrhythmia is an irregular heartbeat occurs when the heart beats too slowly, too rapidly, too early, or irregularly. The arrhythmia monitoring devices are used to track the heart's function, keeping a continuous record of it and assisting in reporting any deviations in the regular rhythm. Arrhythmia monitoring devices include holter monitors, resting ECGs, mobile cardiac telemetry, event monitors, and implantable cardiac monitors.
Arrhythmia Monitoring Devices Market Dynamics
Drivers
- Rising Incidence of Cardiovascular Diseases
The rising incidence of cardiovascular diseases, including atrial fibrillation, bradycardia, and ventricular arrhythmias, drives the demand for arrhythmia monitoring devices. The aging population, sedentary lifestyles, and the growing burden of risk factors such as hypertension and obesity contribute to the increasing prevalence
- Advancements in Monitoring Technologies
Technological advancements in arrhythmia monitoring devices, such as wireless connectivity, remote monitoring capabilities, and improved data analysis algorithms, enhance the accuracy and convenience of monitoring. These advancements drive market growth by improving the efficiency and effectiveness of diagnosis and monitoring
- Growing Adoption of Wearable Devices
The increasing popularity and adoption of wearable devices, including smartwatches and fitness trackers, with built-in arrhythmia monitoring features contribute to market growth. These devices offer convenience, continuous monitoring, and integration with smartphone applications, expanding the reach of arrhythmia monitoring
Opportunities
- Increasing Emphasis on Preventive Cardiology
The growing focus on preventive cardiology presents opportunities for arrhythmia monitoring devices. Early detection and timely intervention through continuous monitoring can help prevent the progression of cardiovascular diseases and reduce the associated morbidity and mortality
- Integration of Artificial Intelligence and Big Data Analytics
The integration of artificial intelligence (AI) and big data analytics in arrhythmia monitoring devices allows for real-time data analysis, pattern recognition, and predictive modeling. This integration offers opportunities to improve diagnosisand treatment planning, optimize monitoring algorithms, and provide personalized insights for patients
Restraints/Challenges
- High Cost of Devices and Limited Reimbursement
High cost of arrhythmia monitoring devices and the associated healthcare services can be a barrier, limiting their accessibility. Additionally, limited reimbursement coverage for certain devices or monitoring periods may affect their widespread adoption
-
Limited Availability of Skilled Healthcare Professionals
The shortage of skilled healthcare professionals trained in arrhythmia diagnosis and interpretation can pose challenges. Adequate training and education programs are required to ensure accurate analysis and interpretation of arrhythmia data obtained from monitoring devices
This arrhythmia monitoring devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the arrhythmia monitoring devices market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Development
- In January 2020, BIOMONITOR III, a novel injectable cardiac monitor from Biotronik, allows for the detection of abnormal heart rhythms. Such new product launches, together with technology advancements, will boost the company's growth potential
Global Arrhythmia Monitoring Devices Market Scope
The arrhythmia monitoring devices market is segmented on the basis of type, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- ECG
- Implantable Monitors
- Holter Monitors
- Mobile Cardiac Telemetry
Application
- Bradycardia
- Tachycardia
- Atrial Fibrillation
- Ventricular Fibrillation
- Premature Contraction
- Others
End-User
- Hospitals and Diagnostic Centers
- Ambulatory Centers
- Others
Arrhythmia Monitoring Devices Market Regional Analysis/Insights
The arrhythmia monitoring devices market is analysed and market size insights and trends are provided by country, type, application and end-user as referenced above
The countries covered in the arrhythmia monitoring devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominating the market due to increasing FDA approval for arrhythmic monitoring devices. Manufacturers of medical devices are constantly investing in monitoring device research and development (R&D), resulting in continuous advancements in monitoring and diagnostic technology
Asia-Pacific is expected the highest growth during the forecast period due to increasing population and introduction of technologies including wearables such as fitness monitors, mobile monitoring systems, and fabric monitoring systems. Furthermore, in the region, the advent of portable and home-based arrhythmia monitors is a significant medical achievement.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The arrhythmia monitoring devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for arrhythmia monitoring devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the arrhythmia monitoring devices market. The data is available for historic period from 2010 to 2020.
Competitive Landscape and Arrhythmia Monitoring Devices Market Share Analysis
The arrhythmia monitoring devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to arrhythmia monitoring devices market.
Some of the major players operating in the arrhythmia monitoring devices market are
- iRhythm Technologies, Inc. (U.S.)
- Medi-Lynx Cardiac Monitoring, LLC. (U.S.)
- AliveCor, Inc. (U.S.)
- B-Secur (U.K.)
- CardioComm Solutions Inc. (Canada)
- General Electric (U.S.)
- Medtronic (Ireland)
- Abbott (U.S.)
- NIHON KOHDEN CORPORATION (Japan)
- Koninklijke Philips N.V. (Netherlands)
- Baxter (U.S.)
- BIOTRONIK (Germany)
- OSI Systems, Inc. (U.S.)
- FUKUDA DENSHI (Japan)
- BioTelemetry (U.S.)
- Spacelabs Healthcare (U.S.)
SKU-